Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Van de Ven
Pulmonary Function (PF) After Stem Cell Transplant (SCT) Is Significantly Better in Children and Adolescents Who Receive Reduced Toxicity Conditioning (RTC) Versus Myeloablative Conditioning (MAC) and Significantly Decreased in Those Who Develop Chronic GVHD (cGVHD)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced Toxicity, Myeloablative Conditioning With BU, Fludarabine, Alemtuzumab and SCT From Sibling Donors in Children With Sickle Cell Disease
Bone Marrow Transplantation
Transplantation
Hematology
Oral Cryotherapy Can Significantly Reduce Oral Mucositis but Not Acute GVHD Incidence in Flu/Mel Conditioning Allo-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced Toxicity Conditioning (RTC) and Allogeneic Stem Cell Transplantation (AlloSCT) for Pediatric Sickle Cell Disease (SCD): Significant Improvement in Physical Functioning
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Factors Associated With Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Donor Mismatch and Acute GVHD Are Associated With Unusually High Mortality in Patients With XIAP Who Underwent Reduced Intensity Conditioning Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML
Bone Marrow Transplantation
Transplantation
Hematology
